AMICUS THERAPEUTICS, INC. Q1 FY2021 Earnings Call

AMICUS THERAPEUTICS, INC. (FOLD)

Earnings Call FY2021 Q1 Call date: 2021-05-10 Concluded

Quarter scorecard

Revenue

$66.40M

+9.7% YoY

Diluted EPS

$-0.25

Gross margin

90.2%

+1.0 pp YoY

Net income

-$65.66M

Non Us $45.55M

+6.5%

United States $20.85M

+17.3%